EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling

Wenshuo Zhao, Jishuang San, Fan Jiang, Yue Zhu, Gaofeng Wu, Jiancheng Yang iD, Weiwei Li

Nutrients · 22.05.2026 · 18 (11) · 1667

DOI: 10.3390/nu18111667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 22.05.2026. Verfasst von Wenshuo Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning Provincial Key Laboratory of Zoonosis, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, C…. Hauptthemen laut MEDLINE: Intestinal Barrier Function, Intestinal Mucosa, Non-alcoholic Fatty Liver Disease, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Modern Agricultural Industry Technology System Construction Project of Broiler Industry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a globally prevalent hepatic disorder, characterized by hepatic lipid accumulation and extrahepatic complications, notably intestinal barrier injury, which further exacerbates MASLD progression. The “gut–liver axis” has been identified as a critical contributor to MASLD development, with insulin-like growth factor 1 (IGF-1) serving as a pivotal coupling factor of this axis. However, the specific role and molecular mechanism by which IGF-1 modulates intestinal barrier function in the context of MASLD remains unclear.

Methods

This study analyzed the correlations between the GH/IGF-1 axis and intestinal barrier function in MASLD rats, and explored the effects of IGF-1 intervention both in vivo and in vitro.

Results

Our results showed that MASLD rats exhibited intestinal barrier impairment, characterized by elevated serum Diamine oxidase (DAO) and D-Lactate (D-LAC) levels, villus damage, and downregulation of tight junction proteins and Mucin (MUC2). These changes were accompanied by suppression of the GH/IGF-1 axis. Correlation analysis uncovered a negative association between IGF-1 levels and markers of barrier dysfunction. IGF-1 intervention effectively repaired the intestinal barrier structure of MASLD rats and significantly upregulated the expressions of IGF-1R, PI3K, and AKT. In vitro, IGF-1 treatment improved transepithelial electrical resistance (TEER), enhanced barrier-related gene expression, promoted cell proliferation, and inhibited apoptosis.

Conclusions

These findings suggested that GH/IGF-1 axis suppression, intestinal barrier dysfunction, and IGF-1R/PI3K/AKT signaling were interconnected within the gut–liver axis in MASLD. IGF-1 may contribute to barrier regulation through associated signaling changes, highlighting the GH/IGF-1 axis as a potential complementary target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intestinal Barrier FunctionIntestinal MucosaNon-alcoholic Fatty Liver DiseaseSignal TransductionAnimalsMaleRatsApoptosisDisease Models, AnimalInsulin-Like Growth Factor ILiverPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRats, Sprague-DawleyReceptor, IGF Type 1

Stichwörter der Autor:innen

IGF-1IGF-1R/PI3K/AKTintestinal mechanical barriermetabolic dysfunction-associated steatotic liver diseaserat

Substanzen

Igf1r protein, ratInsulin-Like Growth Factor Iinsulin-like growth factor-1, ratPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptor, IGF Type 1

Autor:innen und Institutionen

  • Liaoning Provincial Key Laboratory of Zoonosis, College of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.

ORCID-Profile: Jiancheng Yang

Förderung

  • National Natural Science Foundation of China
  • Liaoning Modern Agricultural Industry Technology System Construction Project of Broiler Industry

Zitieren

APA

Zhao, W., San, J., Jiang, F., Zhu, Y., Wu, G., Yang, J., & Li, W. (2026). Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling. Nutrients, 18(11), 1667. https://doi.org/10.3390/nu18111667

Vancouver

Zhao W, San J, Jiang F, Zhu Y, Wu G, Yang J, et al. Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling. Nutrients. 2026;18(11):1667. doi:10.3390/nu18111667

BibTeX
@article{Zhao2026,
  author = {Zhao, Wenshuo and San, Jishuang and Jiang, Fan and Zhu, Yue and Wu, Gaofeng and Yang, Jiancheng and Li, Weiwei},
  title = {Insulin-like Growth Factor 1 Ameliorates Intestinal Barrier Dysfunction in MASLD via IGF-1R/PI3K/AKT Signaling},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1667},
  doi = {10.3390/nu18111667}
}
Kostenlos starten →